Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
CN |
Cash Flow Statement
Cash Flow Statement
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
| Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||||||
| Cash Taxes Paid |
(116)
|
(159)
|
(145)
|
(168)
|
(220)
|
(279)
|
(296)
|
(507)
|
(752)
|
(1 003)
|
(1 164)
|
(1 148)
|
(1 114)
|
(739)
|
(537)
|
(328)
|
(89)
|
(111)
|
(114)
|
(118)
|
(114)
|
(142)
|
|
| Change in Working Capital |
(747)
|
(968)
|
(791)
|
(884)
|
(1 114)
|
(1 263)
|
(1 408)
|
(1 783)
|
(2 185)
|
(2 519)
|
(3 454)
|
(4 265)
|
(4 350)
|
(4 363)
|
(3 855)
|
(3 081)
|
(2 797)
|
(2 603)
|
(2 227)
|
(1 985)
|
(1 788)
|
(1 721)
|
|
| Cash from Operating Activities |
408
N/A
|
501
+23%
|
468
-6%
|
580
+24%
|
725
+25%
|
888
+23%
|
1 682
+89%
|
2 053
+22%
|
3 025
+47%
|
4 161
+38%
|
4 133
-1%
|
3 371
-18%
|
2 578
-24%
|
1 911
-26%
|
1 538
-20%
|
1 861
+21%
|
1 500
-19%
|
845
-44%
|
355
-58%
|
260
-27%
|
160
-38%
|
165
+3%
|
|
| Investing Cash Flow | |||||||||||||||||||||||
| Capital Expenditures |
(293)
|
(403)
|
(390)
|
(515)
|
(649)
|
(855)
|
(1 048)
|
(1 166)
|
(1 179)
|
(1 276)
|
(930)
|
(1 014)
|
(1 007)
|
(853)
|
(1 160)
|
(943)
|
(1 008)
|
(997)
|
(887)
|
(866)
|
(863)
|
(740)
|
|
| Other Items |
84
|
125
|
95
|
86
|
121
|
(8)
|
34
|
43
|
(668)
|
(1 961)
|
(2 584)
|
(2 684)
|
(2 191)
|
(1 287)
|
(894)
|
(683)
|
(715)
|
(391)
|
(616)
|
(990)
|
(700)
|
2
|
|
| Cash from Investing Activities |
(209)
N/A
|
(279)
-33%
|
(295)
-6%
|
(429)
-45%
|
(529)
-23%
|
(863)
-63%
|
(1 014)
-17%
|
(1 123)
-11%
|
(1 847)
-64%
|
(3 237)
-75%
|
(3 514)
-9%
|
(3 699)
-5%
|
(3 198)
+14%
|
(2 141)
+33%
|
(2 054)
+4%
|
(1 626)
+21%
|
(1 723)
-6%
|
(1 388)
+19%
|
(1 503)
-8%
|
(1 856)
-23%
|
(1 562)
+16%
|
(738)
+53%
|
|
| Financing Cash Flow | |||||||||||||||||||||||
| Net Issuance of Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3 461
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
78
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
69
|
57
|
57
|
36
|
(14)
|
123
|
163
|
212
|
138
|
(120)
|
5
|
(19)
|
34
|
167
|
38
|
20
|
(36)
|
(23)
|
(21)
|
(45)
|
8
|
55
|
|
| Cash Paid for Dividends |
(1)
|
(2)
|
(2)
|
0
|
(111)
|
(111)
|
(113)
|
(115)
|
(128)
|
(128)
|
(127)
|
(127)
|
(893)
|
(911)
|
(907)
|
(908)
|
(425)
|
(407)
|
(410)
|
(410)
|
(4)
|
(3)
|
|
| Other |
323
|
323
|
325
|
324
|
(2)
|
(3)
|
3
|
2
|
3 462
|
3 265
|
(212)
|
3 203
|
(214)
|
(31)
|
(24)
|
13
|
(31)
|
(157)
|
(260)
|
(249)
|
(252)
|
(112)
|
|
| Cash from Financing Activities |
391
N/A
|
378
-3%
|
380
+1%
|
359
-6%
|
(127)
N/A
|
8
N/A
|
53
+540%
|
100
+89%
|
3 472
+3 381%
|
3 017
-13%
|
3 127
+4%
|
3 057
-2%
|
(1 073)
N/A
|
(774)
+28%
|
(893)
-15%
|
(875)
+2%
|
(492)
+44%
|
(587)
-19%
|
(613)
-4%
|
(626)
-2%
|
(170)
+73%
|
18
N/A
|
|
| Change in Cash | |||||||||||||||||||||||
| Effect of Foreign Exchange Rates |
1
|
(3)
|
(9)
|
(12)
|
(16)
|
(8)
|
(9)
|
(11)
|
14
|
31
|
26
|
28
|
21
|
(0)
|
8
|
11
|
(2)
|
(5)
|
4
|
4
|
2
|
3
|
|
| Net Change in Cash |
591
N/A
|
596
+1%
|
544
-9%
|
498
-8%
|
54
-89%
|
25
-53%
|
712
+2 695%
|
1 019
+43%
|
4 665
+358%
|
3 972
-15%
|
3 772
-5%
|
2 757
-27%
|
(1 672)
N/A
|
(1 004)
+40%
|
(1 402)
-40%
|
(630)
+55%
|
(717)
-14%
|
(1 136)
-59%
|
(1 757)
-55%
|
(2 218)
-26%
|
(1 570)
+29%
|
(553)
+65%
|
|
| Free Cash Flow | |||||||||||||||||||||||
| Free Cash Flow |
115
N/A
|
97
-15%
|
78
-20%
|
66
-16%
|
76
+15%
|
33
-56%
|
634
+1 806%
|
887
+40%
|
1 847
+108%
|
2 886
+56%
|
3 203
+11%
|
2 356
-26%
|
1 571
-33%
|
1 057
-33%
|
378
-64%
|
918
+143%
|
492
-46%
|
(153)
N/A
|
(532)
-248%
|
(606)
-14%
|
(703)
-16%
|
(575)
+18%
|
|